{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:12:04Z","timestamp":1785798724738,"version":"3.56.0"},"reference-count":35,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,12,8]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Pulmonary hypertension (PH) is defined by elevated mean pulmonary arterial pressure (MPAP), and elevated pulmonary vascular resistance (PVR) reflects pulmonary vascular abnormalities. The clinical significance of non-severe PH in patients with various interstitial lung diseases (ILDs) has not been fully elucidated. We aimed to investigate the clinical significance of MPAP and PVR for mortality in patients with newly diagnosed ILD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively analysed consecutive patients with ILD at initial evaluations that included right heart catheterisation from 2007 to 2018. These patients were classified by MPAP and PVR using the 2022 the European Society of Cardiology (ESC)\/the European Respiratory Society (ERS) guidelines for PH. The clinical significance of MPAP and PVR for mortality was analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among 854 patients, 167 (19.6%) had MPAP&gt;20\u2009mm Hg. The proportion of patients with PVR&gt;2 Wood units (WU) among those with MPAP\u226420\u2009mm Hg, 20&lt;MPAP&lt;25\u2009mm Hg, and \u226525\u2009mm Hg were 26.2%, 60.4% and 86.4%, respectively. In Cox proportional hazards analyses with adjustment for ILD\u2013Gender, Age and Physiology Index, PVR but not MPAP was associated with a higher mortality rate (HR 1.37, 95%\u2009CI 1.23 to 1.52, p&lt;0.0001; HR 0.98, 95%\u2009CI 0.96 to 1.01, p=0.1671, respectively). PVR&gt;2 WU was associated with a higher mortality rate (HR 1.61, 95%\u2009CI 1.28 to 2.02, p&lt;0.0001) even in a group with MPAP\u226420\u2009mm Hg.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Mild elevation of PVR was associated with a higher mortality rate in patients with newly diagnosed ILD, even in those with MPAP\u226420\u2009mm Hg.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thorax-2023-220179","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T18:27:36Z","timestamp":1707157656000},"page":"422-429","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":18,"title":["Mild elevation of pulmonary vascular resistance predicts mortality regardless of mean pulmonary artery pressure in mild interstitial lung disease"],"prefix":"10.1136","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9536-5795","authenticated-orcid":false,"given":"Tomonori","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-1845","authenticated-orcid":false,"given":"Taiki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Teramachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fukihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Yamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7456-5459","authenticated-orcid":false,"given":"Yasuhiro","family":"Kondoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"key":"2025032422450911000_79.5.422.1","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1056\/NEJMra2005230","article-title":"Spectrum of fibrotic lung diseases","volume":"383","author":"Wijsenbeek","year":"2020","journal-title":"N Engl J Med"},{"key":"2025032422450911000_79.5.422.2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1466"},{"key":"2025032422450911000_79.5.422.3","doi-asserted-by":"publisher","DOI":"10.1159\/000345221"},{"key":"2025032422450911000_79.5.422.4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108339","article-title":"Significance of pulmonary arterial pressure as a prognostic indicator in lung-dominant connective tissue disease","volume":"9","author":"Suzuki","year":"2014","journal-title":"PLoS One"},{"key":"2025032422450911000_79.5.422.5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12890-016-0207-3","article-title":"Mean pulmonary arterial pressure as a Prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study","volume":"16","author":"Takahashi","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2025032422450911000_79.5.422.6","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01032-2015"},{"key":"2025032422450911000_79.5.422.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022"},{"key":"2025032422450911000_79.5.422.8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01311-2017","article-title":"A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis","volume":"51","author":"Furukawa","year":"2018","journal-title":"Eur Respir J"},{"key":"2025032422450911000_79.5.422.9","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2025032422450911000_79.5.422.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2025032422450911000_79.5.422.11","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2006.061648"},{"key":"2025032422450911000_79.5.422.12","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-1474"},{"key":"2025032422450911000_79.5.422.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1982.03320430047030"},{"key":"2025032422450911000_79.5.422.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2007.00605.x"},{"key":"2025032422450911000_79.5.422.15","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.112847"},{"key":"2025032422450911000_79.5.422.16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.rmed.2019.03.004","article-title":"Outcomes of lung disease-associated pulmonary hypertension and impact of elevated pulmonary vascular resistance","volume":"150","author":"Awerbach","year":"2019","journal-title":"Respir Med"},{"key":"2025032422450911000_79.5.422.17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.healun.2018.09.011","article-title":"Survival in pulmonary hypertension due to chronic lung disease: influence of low diffusion capacity of the lungs for carbon monoxide","volume":"38","author":"Rose","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"2025032422450911000_79.5.422.18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01483-2021","article-title":"Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry","volume":"58","author":"Olsson","year":"2021","journal-title":"Eur Respir J"},{"key":"2025032422450911000_79.5.422.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00145608"},{"key":"2025032422450911000_79.5.422.20","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00008611"},{"key":"2025032422450911000_79.5.422.21","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30317-9"},{"key":"2025032422450911000_79.5.422.22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216476"},{"key":"2025032422450911000_79.5.422.23","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.healun.2016.12.011","article-title":"Pulmonary hypertension and ventilation during exercise: role of the pre-capillary component","volume":"36","author":"Caravita","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"2025032422450911000_79.5.422.24","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004082","article-title":"Hemodynamic phenotyping of pulmonary hypertension in left heart failure","volume":"10","author":"Naeije","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2025032422450911000_79.5.422.25","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.resinv.2020.12.010","article-title":"Impact of post-capillary pulmonary hypertension on mortality in interstitial lung disease","volume":"59","author":"Teramachi","year":"2021","journal-title":"Respir Investig"},{"key":"2025032422450911000_79.5.422.26","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.02.00068002"},{"key":"2025032422450911000_79.5.422.27","doi-asserted-by":"publisher","DOI":"10.1113\/expphysiol.1995.sp003894"},{"key":"2025032422450911000_79.5.422.28","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12213","article-title":"Pathogenesis, clinical features, and phenotypes of pulmonary hypertension associated with interstitial lung disease: a consensus statement from the pulmonary vascular research Institute\u2019s innovative drug development initiative group 3 pulmonary hypertension","volume":"13","author":"Piccari","year":"2023","journal-title":"Pulm Circ"},{"key":"2025032422450911000_79.5.422.29","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2010-0365TR"},{"key":"2025032422450911000_79.5.422.30","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90510-2"},{"key":"2025032422450911000_79.5.422.31","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-5-343"},{"key":"2025032422450911000_79.5.422.32","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.4.1733"},{"key":"2025032422450911000_79.5.422.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2017.02.016"},{"key":"2025032422450911000_79.5.422.34","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00115511"},{"key":"2025032422450911000_79.5.422.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-019-0932-5","article-title":"Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease","volume":"19","author":"Nemoto","year":"2019","journal-title":"BMC Pulm Med"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2023-220179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T06:06:08Z","timestamp":1742882768000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2023-220179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,15]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/thorax-2023-220179"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2023-220179","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]}}}